ArticleMolecular medicine reports2020

Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.

Chao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.